OCD Trial, Recruiting NCT06596447 Sponsor: Baylor College of Medicine Condition: OCD
Back to Ocd

OCD Trial, Recruiting

NCT06596447
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been formally diagnosed with Obsessive-Compulsive Disorder (OCD) as their main condition, according to standard diagnostic guidelines (DSM-5)
  • Adults aged between 18 and 64 years old
  • People who have had severe, treatment-resistant OCD for at least five years, where the condition causes significant distress and affects daily life
  • People whose OCD symptoms score at least 28 on a standard OCD severity rating scale called the Y-BOCS, indicating severe symptoms
  • People for whom at least three different SSRI antidepressant medications have been tried adequately without sufficient benefit
  • People for whom the antidepressant medication clomipramine has been tried adequately without sufficient benefit
  • People for whom adding at least one antipsychotic medication to the above treatments has also not provided sufficient benefit
  • People who have completed an adequate course of a specific type of talking therapy for OCD (called CBT with Exposure and Response Prevention), amounting to at least 25 documented hours with a specialist therapist, without sufficient benefit
  • People whose psychiatric medications have remained stable for the month before surgery
  • People who have been approved by a specialist multi-disciplinary medical team to undergo a brain surgery procedure called Deep Brain Stimulation (DBS) within two months of enrolling in the trial
  • People who are able to give fully informed written consent to participate
  • People who have a family member or close support person willing to attend study visits with them if needed

Who may not be able to join:

  • People who have ever been diagnosed with a psychotic disorder, such as schizophrenia
  • People who have experienced alcohol or substance abuse or dependence within the past six months (excluding nicotine)
  • People considered by the study team to be at high risk of suicidal behaviour or impulsivity
  • People who are currently pregnant or plan to become pregnant within the next 24 months
  • People who require a medical treatment called diathermy (a type of heat-based therapy, sometimes used in physiotherapy or surgery)
  • People who have a neurological or other medical condition that the study team considers would make participation in the study procedures unsafe or unsuitable
  • People who have another psychiatric condition that, in the study team's opinion, may interfere with their ability to participate in study activities
  • People whose primary diagnosis is Hoarding Disorder rather than OCD

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 713-798-5060

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 August 2025
Est. completion
31 July 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Changes in OCD symptoms

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov